Overview

Hyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-Guérin Immunotherapy (BCG) for Superficial Bladder Cancer

Status:
Terminated
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The study is designed to compare the efficacy and safety of 2 treatment types for the prevention of tumor recurrence of superficial bladder cancer: 1. A combination of bladder wall heating and local chemotherapy (Synergo) 2. Bacillus Calmette-Guérin (BCG)
Phase:
Phase 3
Details
Lead Sponsor:
Medical Enterprises Europe B.V.
Treatments:
BCG Vaccine
Mitomycin
Mitomycins